Can Nutanix Turn Itself Around After This Dismal Q3 Report?
Nutanix shares tumbled after it released its most recent quarterly results and offered disappointing guidance.
All Work
Chris Lange
Uber vs Lyft: Who Won the First Round of Ride-Share Earnings?
Uber reported its first quarter financial results Thursday after the markets closed.
Should Costco Get More Credit for Its Q2 Earnings?
Costco Wholesale rose marginally early Friday even though it reported better than expected quarterly results late on Thursday.
Why Cara Therapeutics Could Rise Another 50%
Cara Therapeutics recently announced data from its late-stage trial in patients with chronic kidney disease. While there was a very positive reaction among investors, one analyst believes that this stock could soar even higher.
Is. J.Jill Facing Existential Threat With Other Womens Retailers?
J.Jill shares were absolutely crushed on Thursday morning after the company reported its fiscal first-quarter financial results.
Dollar General or Dollar Tree: Who Had the Better Q1 Report?
Dollar General and Dollar Tree each released its fiscal first-quarter financial results before the markets opened on Thursday. The question is which retailer had the better report?
AstraZeneca Cuts Almost All Ties to Inovio Pharma
Inovio Pharmaceuticals shares dipped on Wednesday after it was announced that the firm’s partnership with AstraZeneca would be scaled back.
What to Expect When Dollar General Reports Thursday
Dollar General is scheduled to release its fiscal first quarter financial results before the markets open on Thursday. The consensus estimates are calling for $1.39 in earnings per share (EPS) and $6.56 billion in…
Bed Bath & Beyond Succumbs to Activists
Bed Bath & Beyond is in the midst of transformational changes to the organization. Now, the retailer is making some big changes at the top — in its board of directors.
AMC Entertainment’s Unbelievable Membership Growth
AMC Entertainment has seen incredible success over the past few years in its loyalty program. Despite this announcement, shares were pulled down by market headwinds on Wednesday.
What This Cara Therapeutics Late-Stage Study Could Mean for Chronic Kidney Disease
Cara shares jumped on Wednesday after the firm announced topline data from its late-stage trial in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus.
Abercrombie & Fitch Squashes Its Own Turnaround
Abercrombie & Fitch released disappointing fiscal first-quarter financial results before the markets opened on Wednesday.
Consumer Confidence Unwavering Despite China Trade War
Despite trade tensions with China in the past few weeks, consumer confidence is relatively high, according to the Conference Board. In fact, the numbers are near an 18-year high.
Is SeaWorld on the Rise?
SeaWorld shares jumped on Tuesday after the firm announced a series of share repurchases. Could this renewed faith in SeaWorld signal a return to prominence?
Is This Kezar Life Sciences Lupus Study in Trouble?
Kezar Life Sciences shares were absolutely crushed on Tuesday after the firm revealed data from its midstage trial in patients with systemic lupus erythematosus.
How High Huawei Ranks Among Smartphone Producers
For the first quarter, the Chinese telecom firm Huawei ranked as the world’s second largest smartphone vendor, according to the research and advisory firm Gartner. This is despite facing a ban in the United…
Is Amazon Looking to Get Back Into NYC?
Amazon is reportedly on the hunt for office space in Manhattan’s West Side, despite deciding against building a headquarters in Queens.
Short Sellers Get Even Higher on Cannabis Stocks
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Big Pharma Short Sellers Hike Their Bets
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Major Biotechs See a Rising Tide in Short Interest
The May 15 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks increased.